Trial Profile
A Study to Compare the Efficacy of Pemetrexed-based Chemotherapy in Patients With Advanced ROS1-Fusion Lung Adenocarcinoma With Those Having Different Driver Mutations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 28 Apr 2016 New trial record
- 16 Apr 2016 Results published in the Journal of Thoracic Oncology